# BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)

> **NCT00186329** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 100 (—)

## Conditions studied

- Congestive Heart Failure Exacerbation
- Renal Insufficiency

## Interventions

- **DRUG:** Natrecor, a recombinant form of B-type Natriuretic Peptide, made by Scios, Inc. vs. placebo

## Key facts

- **NCT ID:** NCT00186329
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 100 (—)
- **Last updated:** 2015-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00186329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00186329, "BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00186329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*